Statistics for PDS Biotechnology (id:5479 PDSB)
Valuation metrics
Market cap
73.64M
Enterprise value
40.65M
Trailing P/E (ttm)
-1.50
Forward P/E
-1.42
PEG ratio
-1.42
Price/Sales (ttm)
Price/Book (mrq)
2.53
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.02
Overview
Shares outstanding
36.82M
Float
35.43M
Shares short
4.47M
% Held by insiders
0.04%
% Held by institutions
0.12%
Average volume (10 days)
741.27K
Average volume (90 days)
Price summary
52-Week low
1.53
52-Week high
6.68
52-Week change
-201.91%
Beta
1.93
50-Day moving average
3.21
200-Day moving average
3.65
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
March 18th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
March 18th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-39.95%
Return on equity
-128.40%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-39,650,236.00
Net income to common (ttm)
-40,678,760.00
Diluted EPS (ttm)
-1.23
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
57.73M
Total cash per share (mrq)
1.57
Total debt (mrq)
24.38M
Total Debt/Equity (mrq)
78.85
Current ratio (mrq)
383.80%
Book value per share (mrq)
0.79
Cash flow
Cash flow statement
-34,429,204.00
Levered free cash flow (LFCF)
-22,477,140.00